Geron
GERN
#6239
Rank
A$1.25 B
Marketcap
A$1.97
Share price
0.00%
Change (1 day)
-57.55%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -A$72.15 Million

According to Geron's latest financial reports the company's current earnings are A$0.18 Billion. In 2024 the company made an earning of -A$0.23 Billion, an increase over its 2023 earnings that were of -A$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$72.15 Million-67.81%
2024 -A$0.23 Billion-11.23%
2023 -A$0.26 Billion30.22%
2022 -A$0.2 Billion20.15%
2021 -A$0.17 Billion50.08%
2020 -A$0.11 Billion4.46%
2019 -A$0.11 Billion130.68%
2018 -A$44.63 Million8.84%
2017 -A$41 Million-3.08%
2016 -A$42.3 Million-22080.6%
2015 A$0.19 M-100.38%
2014 -A$51.11 Million-7.14%
2013 -A$55.04 Million
2011 -A$0.14 Billion19.04%
2010 -A$0.11 Billion8.45%
2009 -A$0.11 Billion-2.51%
2008 -A$0.11 Billion14.65%
2007 -A$90.24 Million32.68%
2006 -A$68.01 Million25.59%
2005 -A$54.16 Million4.36%
2004 -A$51.89 Million19.73%
2003 -A$43.34 Million-15.46%
2002 -A$51.27 Million1.94%
2001 -A$50.29 Million33.59%
2000 -A$37.65 Million27.53%
1999 -A$29.52 Million63.13%
1998 -A$18.1 Million15.6%
1997 -A$15.66 Million-10.66%
1996 -A$17.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$14.19 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$2.28 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$99.43 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.16 B-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.63 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA